glp-1 with cv benefit Semaglutide shows benefits beyond weight loss, study finds | Raj Reddy posted on the topic Prescribe SGLT2 inhibitors, GLP-1 receptor
Description
These trials were performed in a one-way shuttle box (MED-APAP-D1R
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
The exciting beyond obesity frontier for GLP-1 drugs is their potential to treat conditions where inflammation, or other non-obesity factors, are the primary cause
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [grant numbers CIFMS2017-I2M-1-008, CIFMS2021-I2M-1-002]
